INTRODUCTION {#sec1-1}
============

Body mass index (BMI) is a universal parameter derived from the weight and height of an individual. It is easily calculated as weight in kilogrammes divided by square of height in metres and has high specificity. According to BMI, people with obesity have increased risk of diseases such as type 2 diabetes, hypertension, heart attack and hyperlipidaemia, which can cause poor surgical outcomes.\[[@ref1]\] Obesity in adulthood is also associated with short life expectancy and is a predictor of mortality at old ages.\[[@ref2]\] However, the impact of being underweight is not well known or only for external causes such as increased risk of dying.\[[@ref3]\]

The criteria for classifying obesity using BMI are reported to possibly not be appropriate for different populations. Risks of even low BMI can be increased in Asians who are diagnosed with visceral or abdominal obesity. Therefore, the World Health Organization (WHO) redefined obesity as 25 kg/m^2^ for Asia-Pacific populations in 2000.\[[@ref4]\] In 2004, WHO Expert Consultation also proposed a BMI cut-off of 23 kg/m^2^ for determining public health and clinical action in Asia.\[[@ref5]\] The outcomes of this new standard and its oncologic outcomes have not been reported, especially for low BMI patients.

Therefore, this study was designed to compare short- and long-term outcomes of underweight, normal range, pre-obese and obese patients using BMI for Asians following laparoscopic resection for colorectal cancer.

PATIENTS AND METHODS {#sec1-2}
====================

A total 2640 patients underwent laparoscopic R0 resection for colorectal cancer from September 2006 to March 2015 at a tertiary referral hospital. Data were collected prospectively and analysed retrospectively.

Perioperative parameters and oncologic outcomes were analysed according to four groups using the WHO Asia-Pacific perspective:\[[@ref4]\] under 18.5 kg/m^2^ as the underweight group, between 18.5 and 22.9 kg/m^2^ as the normal range group, 23--24.9 kg/m^2^ as the pre-obese group and over 25 kg/m^2^ as the obese group. Open conversion cases were included to analyse whether it was due to obesity. A total of 2408 patients were included and classified as the underweight (*n* = 112), normal range (*n* = 886), pre-obese (*n* = 655) and obese (*n* = 755). All surgeries were performed by two senior colorectal surgeons with extensive laparoscopic experience.

Post-operative complications and mortality were defined as complications or death occurring within 30 days following surgery or during hospitalisation. Oncologic outcomes were measured as recurrence (local and distant metastasis), overall survival and cancer-specific survival. Recurrence was defined as a recurrent lesion detected by radiologic, clinical, intraoperative or pathologic method.

Statistical analyses {#sec2-1}
--------------------

Differences between groups were estimated with one-way analysis of variance, Kruskal--Wallis test for continuous data and linear-by-linear association for categorical data. Probability of recurrence and survival was estimated by Kaplan--Meier curve analysis with the exception of Stage IV. Statistical analyses used SPSS (IBM, SPSS Statistics, Version 20, Armonk, NY, USA). *P* \< 0.05 was considered statistically significant.

RESULTS {#sec1-3}
=======

From our colorectal database of 2408 patients, there were 1477 (61.3%) men and 931 women (38.7%) with a mean age of 61.9 years. Mean BMI for total patients was 23.6 kg/m^2^. No significant differences were observed between groups in age, sex, cancer location and pre-operative CEA as pre-operative parameters. Although the proportion of diabetes mellitus did not show significant differences, the rate of hypertension increased with BMI (*P* \< 0.001) \[[Table 1](#T1){ref-type="table"}\].

###### 

Demographics and characteristics

![](JMAS-14-134-g001)

By analysis of operative outcomes, the underweight group had higher estimated blood loss than the other groups (*P* = 0.019). Conversion rate was the highest in the underweight group (2.7%, *P* \< 0.001). Causes of conversion from minimally invasive surgery to an open conversion were bulky tumours such as T4 cancers (0.7%, 17 of 2408) with or without obstruction, fatty obesity (*n* = 4, 0.2%), adhesions from previous operations (*n* = 3, 0.1%), uncontrolled bleeding (*n* = 3, 0.1%) and poor visualisation resulting from instrument or assistant error (*n* = 17, 0.7%) \[[Table 2](#T2){ref-type="table"}\].

###### 

Operative outcomes

![](JMAS-14-134-g002)

The obese group had the fewest harvested lymph nodes (mean 21.7, *P* \< 0.001). No significant differences were seen in post-operative complications or length of post-operative hospital stay. There were also no differences in TNM staging, adjuvant chemotherapy and radiation therapy \[[Table 3](#T3){ref-type="table"}\].

###### 

Post-operative outcomes

![](JMAS-14-134-g003)

Comparison of oncologic outcomes except for Stage IV showed that median follow-up was 34--37 months. The underweight group had the highest recurrence rate (29.5%, *P* = 0.050), the poorest overall survival (*P* = 0.007) and cancer-specific survival (*P* = 0.002) \[[Table 4](#T4){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}\].

###### 

Long-term outcomes except Stage IV (*n*=2082)
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![Kaplan--Meier curves of recurrence-free survival, overall survival and cancer-specific survival classified by obesity status](JMAS-14-134-g005){#F1}

Analysis of poor oncologic outcomes showed no significant differences in occupation or educated level of the patients. However, the underweight group had the lowest proportion of national health insurance and the highest medical care (*P* = 0.012) \[[Table 5](#T5){ref-type="table"}\].

###### 

Socioeconomic status except Stage IV
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DISCUSSION {#sec1-4}
==========

Analysis using the new BMI classification from the WHO Asia-Pacific perspective for Asians showed hypertension increased with BMI, and a group of obese patients had a longer operative duration and fewer harvested lymph nodes than other groups. The underweight group had higher estimated blood loss during the surgery and also higher conversion rate than other groups. The underweight group had the poorest long-term outcomes for overall survival and cancer-specific survival, which might be linked to their health insurance.

The impact of obesity on short-term outcomes was first introduced in 2000.\[[@ref6]\] Since then, relevant discussions have included cross-ethnic population studies for Asians in China, Hong Kong, India, Japan, Korea, Malaysia and Singapore.\[[@ref5][@ref7][@ref8]\] A Japanese study investigated the influence of obesity on short-term and long-term outcomes after laparoscopic colonic surgery in 2014. However, the BMI criteria for obesity were 30 kg/m^2^.\[[@ref9]\] Due to inaccurate results, several studies from Japan used visceral obesity as a parameter instead of BMI. Ishii *et al*. showed visceral obesity (odds ratio 1.0, 95% confidence interval: 1.2--84.5, *P* = 0.035) as an independent risk factor along with low rectal cancer and smoking.\[[@ref10]\] Tsujinaka *et al*. concluded that visceral fat area is a more useful standard than BMI for patients over 25 kg/m^2^.\[[@ref11]\] A prospective, randomised trial of oncologic outcomes associated with BMI and colorectal cancer showed that only obese women (BMI \>30 kg/m^2^) had worse overall mortality but had no significant difference in recurrence.\[[@ref12]\] The effect of adjuvant chemotherapy on BMI for colon cancer is controversial. Patients with BMI over 35 kg/m^2^ experienced increased risk of recurrence and death though they received adjuvant chemotherapy for colon cancer.\[[@ref13]\] However, increased BMI during adjuvant chemotherapy was not related to a high recurrence of death in a cohort study of Stage III colon cancer.\[[@ref14]\]

Our results showed that the underweight, not the obese group, had the lowest overall and cancer-specific survival compared to other groups. A study showed that underweight patients (BMI \<20 kg/m^2^) with colon cancer had increased mortality although the study concluded that the cause of death was not related to cancer,\[[@ref15]\] which phenomenon had been introduced in the previous year as the obesity paradox.\[[@ref16]\] Roh *et al*.\[[@ref3]\] reported that only external causes such as frailty, alcohol or drug abuse increase the risk of dying for underweight individuals in a census-linked cohort of 21,578 individuals with up to 32 years of follow-up. Studies of Western\[[@ref17]\] and Eastern\[[@ref18]\] populations on whether underweight can be a risk factor for death have not clearly been explained and is still a matter of debate.

Health seems to result from a mixture of biological, environmental and behavioural factors rather than from a single cause. However, recently, sociological papers have found that socioeconomic status has a strong relationship with health, even when controlling for economic resources and access to healthcare.\[[@ref19]\] Although income and employment were not exactly analysed in this study, a review article from Japan showed a positive relationship between educational and occupational class and health.\[[@ref20]\] Therefore, a reasonable hypothesis is that, in this study, the poorest outcomes in the underweight group might have been linked to socioeconomic status.

The rate of open conversion cases was extremely low (1.8%, 43 of 2408), but the underweight group had the highest conversion rate (2.7%, *P* \< 0.001) in this study. The main factor which caused the highest conversion rate in the underweight group was bleeding during the surgery, which also related with the highest estimated blood loss in the underweight group. However, statistical differences appear to be due to very low incidence rates in this study. The relationship between BMI and conversion rate is also a matter of debate. A prospective study from Germany showed no significance in conversion rate based on BMI (7.3% in the obese vs. 9.5% in the non-obese group, *P* \> 0.05).\[[@ref21]\] However, a study from 2002 on stability with high BMI using laparoscopy for colorectal cancer showed higher conversion rate (39 vs. 13.5%, *P* = 0.01) in the obese group.\[[@ref22]\] Their consecutive results also showed a higher conversion rate (23.7 vs. 10.9%, no *P* value provided).\[[@ref23]\]

Although we showed that fewer lymph nodes were harvested from patients in the pre-obese and obese groups than other groups, other studies found no significant difference between non-obese and obese groups.\[[@ref24][@ref25][@ref26]\] A Japanese case-matched study analysing 152 patients also reported that the median number of harvested lymph nodes was not affected by obesity (high vs. low BMI, 17 vs. 17, *P* = 0.97).\[[@ref9]\] In the area of gastric resection, Dhar *et al*.\[[@ref27]\] in a study on 787 patients showed that significantly fewer lymph nodes were removed following D2 (high vs. low BMI, 21 vs. 28, *P* = 0.002) and D3 (31 vs. 37, *P* = 0.023) dissections.

This study has several limitations. First, it was a retrospective study of prospectively collected data. Therefore, important parameters might have been missed in the analysis. The design may also have led to selection bias despite the use of prospectively collected data. Second, the number of patients in the normal range was one-third (36.8%) of the study population, whereas obesity was 31.4% (755 of 2408 patients). These percentages were comparable or higher than Western populations.\[[@ref6][@ref23]\] Pre-operative BMI might not reflect weight loss or malnutrition in patients who received neoadjuvant or adjuvant treatment. Third, the collected data for an analysis of socioeconomic status had limitations; patients' incomes or property and states of employment were not collected. Therefore, mean age over 65 just marked as retirement or unemployed state.

CONCLUSION {#sec1-5}
==========

The obese group had the fewest harvested lymph nodes, whereas the underweight group had the highest estimated blood loss, conversion rate to open approaches and the poorest overall and cancer-specific survivals.
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